Makoto Ota
Founder bij WELBE, INC.
Vermogen: 39 M $ op 31-03-2024
Profiel
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
WELBE,INC.
20.00% | 27-03-2024 | 5 512 154 ( 20.00% ) | 39 M $ | 31-03-2024 |
Actieve functies van Makoto Ota
| Bedrijven | Functie | Begin |
|---|---|---|
| WELBE, INC. | Founder | 01-12-2011 |
| Welbe Healthcare, Inc. | Director/Board Member | 01-06-2021 |
Eerdere bekende functies van Makoto Ota
| Bedrijven | Functie | Einde |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
